Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

In this work we provide an experimental workflow of how active enhancers can be identified and experimentally validated.

Abstract

Embryonic development is a multistep process involving activation and repression of many genes. Enhancer elements in the genome are known to contribute to tissue and cell-type specific regulation of gene expression during the cellular differentiation. Thus, their identification and further investigation is important in order to understand how cell fate is determined. Integration of gene expression data (e.g., microarray or RNA-seq) and results of chromatin immunoprecipitation (ChIP)-based genome-wide studies (ChIP-seq) allows large-scale identification of these regulatory regions. However, functional validation of cell-type specific enhancers requires further in vitro and in vivo experimental procedures. Here we describe how active enhancers can be identified and validated experimentally. This protocol provides a step-by-step workflow that includes: 1) identification of regulatory regions by ChIP-seq data analysis, 2) cloning and experimental validation of putative regulatory potential of the identified genomic sequences in a reporter assay, and 3) determination of enhancer activity in vivo by measuring enhancer RNA transcript level. The presented protocol is detailed enough to help anyone to set up this workflow in the lab. Importantly, the protocol can be easily adapted to and used in any cellular model system.

Introduction

Development of a multicellular organism requires precisely regulated expression of thousands of genes across developing tissues. Regulation of gene expression is accomplished in large part by enhancers. Enhancers are short non-coding DNA elements that can be bound with transcription factors (TFs) and act from a distance to activate transcription of a target gene1. Enhancers are generally cis-acting and most frequently found just upstream of the transcription start site (TSS), but recent studies also described examples where enhancers were found much further upstream, on the 3' of the gene or even within the introns and exons2.

Protocol

1. Enhancer Selection Based on Chip-seq Analysis

  1. Download the RXR ChIP-seq raw data fastq file (mm_ES_RXR_24h_ATRA.fastq.gz) from http://ngsdebftp.med.unideb.hu/bioinformatics/
  2. Download and extract the required BWA index file for the alignment (in our case: Mus_musculus_UCSC_mm10).(ftp://igenome:G3nom3s4u@ussd-ftp.illumina.com/Mus_musculus/UCSC/mm10/Mus_musculus_UCSC_mm10.tar.gz
    NOTE: Visit to https://github.com/ahorvath/Bioinformatics_scripts for more information regarding the steps of bioinformatics analysis and to download the scripts used below.
  3. Align the example fastq file to mm10 genome (use the script: perform_alignment.sh....

Representative Results

We used a pan-specific RXR antibody in order to identify genome-wide which RA-regulated genes have receptor enrichment in their close proximity. Bioinformatics analysis of RXR ChIP-seq data obtained from ES cells treated with retinoic acid revealed the enrichment of the nuclear receptor half site (AGGTCA) under the RXR occupied sites (Figure 1). Using a bioinformatics algorithm we mapped back the motif search result for the half site to the RXR ChIP-seq data (Figu.......

Discussion

In recent years, advances in sequencing technology have allowed large-scale predictions of enhancers in many cell types and tissues 7-9. The workflow described above allows one to perform primary characterization of candidate enhancers chosen based on ChIP-seq data. The detailed steps and notes will help anyone to set up a routine enhancer validation in the lab.

The most critical step in the luciferase reporter assay is the transfection efficiency. It is recommended to include a GFP.......

Disclosures

The authors have nothing to disclose.

Acknowledgements

The authors would like to acknowledge Dr. Bence Daniel, Matt Peloquin, Dr. Endre Barta, Dr. Balint L Balint and members of the Nagy laboratory for discussions and comments on the manuscript. L.N is supported by grants from the Hungarian Scientific Research Fund (OTKA K100196 and K111941) and co-financed by the European Social Fund and the European Regional Development Fund and Hungarian Brain Research Program - Grant No. KTIA_13_NAP-A-I/9.

....

Materials

NameCompanyCatalog NumberComments
KOD DNA polymeraseMerck Millipore71085-3for PCR amplification of enhancer from gDNA
DNeasy Blood & Tissue kit Qiagen69504for genomic DNA isolation
QIAquick PCR Purification kitQiagen28106for PCR product purification
Gel extraction kit Qiagen28706for gel extraction if there are more PCR product
HindIIINEBR3104Lrestriction enzyme
BamHINEBR3136Lrestriction enzyme
FastAPThermo ScientificEF0651release of 5'- and 3'-phosphate groups from DNA
T4 DNA ligaseNEBM0202for ligation
QIAprep Spin Miniprep kitQiagen27106for plasmid isolation
DMEMGibco31966-021ES media
FBSHycloneSH30070.03ES media
MEM Non-Essential Amino AcidSigmaM7145ES media
Penicillin-StreptomycinSigmaP4333ES media
Beta MercaptoethanolSigmaM6250ES media
FuGENE HD PromegaE2311transfection reagent
Opti-MEM® I Reduced Serum MediumLife Technologies31985-062for transfection
All-trans retinoic acidSigmaR2625ligand, for activation of RAR/RXR
96-well clear plateGreiner655101for Beta galactosidase assay
96-well white plateGreiner655075for Luciferase assay
D-luciferin, potassium saltGoldbio.com115144-35-9for Luciferase assay
ATP saltSigmaA7699-1Gfor Luciferase assay
MgSO4x 7H2OSigma230391-25Gfor Luciferase assay
HEPESSigmaH3375-25Gfor Luciferase assay
Na2HPO4 x 7H2OSigma431478-50Gfor Beta galactosidase assay
NaH2PO4 x H2OSigmaS9638-25Gfor Beta galactosidase assay
MgSO4 x 7H2OSigma230391-25Gfor Beta galactosidase assay
KClSigmaP9541-500Gfor Beta galactosidase assay
ONPG (o-nitrophenyl-β-D-galactosidase)SigmaN1127-1Gfor Beta galactosidase assay
TRIzol®Life Technologies15596-026RNA isolation
High-Capacity cDNA Reverse Transcription KitLife Technologies4368814reverse transcription of eRNA
Rnase-free DnasePromegaM6101Dnase treatment
SsoFast Eva GreenBioRad750000105RT-qPCR mastermix
CFX384 Touch™ Real-Time PCR Detection SystemBioRadqPCR machine
BioTek Synergy 4 microplate readerBioTekluminescent counter

References

  1. Wamstad, J. A., Wang, X., Demuren, O. O., Boyer, L. A. Distal enhancers: new insights into heart development and disease. Trends in cell biology. 24, 294-302 (2014).
  2. Pennacchio, L. A., Bickmore, W., Dean, A., Nobrega, M. A., Bejerano, G. Enhancers: fi....

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Gene Regulatory ElementsEnhancersRetinoic AcidEmbryonic Stem Cell DifferentiationReporter Plasmid ConstructTransfectionTranscription Regulation

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved